PALO ALTO, Calif.--Maker of genomics database products, Incyte Pharmaceuticals extended for three more years its collaboration with Pfizer and expanded the scope of its original 1994 agreement to allow Pfizer access to a proprietary Incyte database of full-length genes and a DNA clone set. Pfizer will have continued access to the gene sequence and expression database it has contracted since 1994. Financial terms of the agreement were not disclosed.
Incyte and Pfizer Expand Database Agreement
Dec 21, 1998